Skip to content

Unexpected ABR Results in Patients Suspected With Auditory Neuropathy Spectrum Disorder

Unexpected ABR Results in Patients Suspected With Auditory Neuropathy Spectrum Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06125015
Enrollment
11
Registered
2023-11-09
Start date
2015-01-20
Completion date
2021-11-30
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auditory Neuropathy

Brief summary

This study aimed to assess the clinical evaluations and potential underlying pathologies in patients diagnosed with Auditory Neuropathy Spectrum Disorder (ANSD) who exhibited unusual results in audiological tests. The research involved the retrospective analysis of audiological tests of 11 patients conducted by expert audiologists at Istanbul Medipol Mega Hospital between 2010 and 2020. These patients displayed abnormalities in their Auditory Brainstem Response (ABR) tests. The study sought to investigate patients with ANSD who presented atypical audiological findings, shedding light on the associated clinical aspects and potential causes of such anomalies.

Interventions

DIAGNOSTIC_TESTHearing Thresholds Assessments

Auditory Neuropathy Spectrum Disorder (ANSD) is a type of hearing disorder that affects the transmission of sound signals from the inner ear to the brain. In individuals with ANSD, the outer hair cells in the cochlea, which are responsible for amplifying sound, typically function properly. However, there is a disruption in the transmission of auditory information from the cochlea to the auditory nerve and then to the brain. It is characterized by a mismatch between the results of objective hearing tests, such as Auditory Brainstem Response (ABR), and subjective hearing experiences. In ABR tests, the responses of the auditory nerve to sounds may be abnormal, while the individual perceives their hearing to be better than suggested by the test results. In this study we showed ANSD patients with abnormal ABR results by using ABR, Otoacoustic Emissions, Tympanometry and behavioral test batteries.

Sponsors

Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to 46 Years
Healthy volunteers
No

Inclusion criteria

* Presence of wave V with cochlear microphonics

Exclusion criteria

* Type B tympanogram

Design outcomes

Primary

MeasureTime frameDescription
Measuring Hearing Thresholds with Electrophysiological Tests6 yearsParticipants' hearing thresholds and cochlear microphonics evaluated by using Auditory Brainstem Responses and Otoacoustic Emissions.
Evaluating Middle Ear Pathologies6 yearsParticipants' middle ear pathologies evaluated by using Tympanometry
Evaluating Hearing Thresholds by Using Behavioral Tests6 yearsParticipants' reactions to sounds were assessed using Free Field Audiometry or headphones. These evaluations were conducted initially at the time of diagnosis and subsequently after the patients had started using hearing aids.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026